Clinical trials update from the American Heart Association meeting 2009: HEAAL, FAIR-HF, J-CHF, HeartMate II, PACE and a meta-analysis of dose-ranging studies of beta-blockers in heart failure-Reference-Cited by-同舟云学术

Clinical trials update from the American Heart Association meeting 2009: HEAAL, FAIR-HF, J-CHF, HeartMate II, PACE and a meta-analysis of dose-ranging studies of beta-blockers in heart failure

Published:2010-01-18 Issue:2 Volume:12 Page:197-201
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Cleland John G.F.¹,Coletta Alison P.¹,Freemantle Nick²,Ahmed Daniyal¹,Rubis Pawel¹,Clark Andrew L.¹

Affiliation:

1. Department of Cardiology, Hull York Medical School; University of Hull, Castle Hill Hospital, Cottingham; Kingston-upon-Hull HU16 5JQ UK

2. School of Health and Population Sciences, Primary Care Clinical Sciences Building; University of Birmingham; Edgbaston Birmingham B15 2TT UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II;Pitt;Lancet,2000

2. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan;Dickstein;Lancet,2002

3. Clinical trials update from the American Heart Association meeting: Ώ-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PAD and DEFINITE;Cleland;Eur J Heart Fail,2004

4. Design of the heart failure endpoint evaluation of A-II antagonist losartan (HEAAL) study in patients intolerant to ACE-inhibitor;Konstam;Eur J Heart Fail,2008

5. Effects of high dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial;Konstam;Lancet,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction;Cochrane Database of Systematic Reviews;2021-05-22

2. Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin;Indian Heart Journal;2018-12

3. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction;Cochrane Database of Systematic Reviews;2018-06-28

4. Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure;Journal of the American College of Cardiology;2017-06

5. High Dose β-Blocker Therapy Triggers Additional Reverse Remodeling in Patients With Idiopathic Non-Ischemic Cardiomyopathy;International Heart Journal;2016